DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Monday reported third-quarter net income of $12.9 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Durham, North Carolina-based company said it had profit of 6 cents.
The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 7 cents per share.
The drugmaker posted revenue of $159.4 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $161.2 million.
BioCryst shares have fallen roughly 3% since the beginning of the year. The stock has fallen 13% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BCRX at https://www.zacks.com/ap/BCRX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
